logo
Select company
Select metric
$ 2.05MNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
32
Sector
58
Industry
69
History
41
$ 1.6Close
$ 1.35 - $ 2.49 52-Week Range
Ticker Information

Ticker

BRTX

Company Name

BIORESTORATIVE THERAPIES INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

BIORESTORATIVE THERAPIES INC - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BRTX - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025$ 2.05M
3/31/2025$ 1.13M
12/31/2024$ 0
9/30/2024$ 83.07K
6/30/2024$ 1.94M
3/31/2024$ 2.35M
12/31/2023$ 2.35M
9/30/2023$ 2.27M
6/30/2023$ 411.7K
3/31/2023$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • BIORESTORATIVE THERAPIES INC's latest trailing twelve months (TTM) CF - Equity stands at $ 1.66M.
  • Over the past 5 years, BIORESTORATIVE THERAPIES INC's average CF - Equity has been $ 4.55M.
  • The median CF - Equity for BIORESTORATIVE THERAPIES INC during this period was $ 1.1M
  • BIORESTORATIVE THERAPIES INC reached its highest CF - Equity over the past 5 years at $ 21.07M.
  • The lowest CF - Equity recorded by BIORESTORATIVE THERAPIES INC in the same timeframe $ 0

BIORESTORATIVE THERAPIES INC's CF - Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Equity Benchmarks
CompanyCF - Equity
ERNA : ERNEXA THERAPEUTICS INC $ 5.93MLYRA : LYRA THERAPEUTICS INC $ 5MLEXX : LEXARIA BIOSCIENCE CORP $ 6.05MVYNE : VYNE THERAPEUTICS INC $ 0APRE : APREA THERAPEUTICS INC $ 573.98KIBIO : IBIO INC $ 3.67MSXTP : 60 DEGREES PHARMACEUTICALS INC $ 6.84MHCWB : HCW BIOLOGICS INC $ 6.93MICU : SEASTAR MEDICAL HOLDING CORP $ 18.11MPCSA : PROCESSA PHARMACEUTICALS INC $ 12.24M

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

BRTX - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ 0

Minimum

Mar 31, 2021

$ 21.07M

Maximum

Dec 31, 2021

$ 4.55M

Average

$ 1.1M

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 107.22K with a standard deviation of $ 17.65M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.89K
min$ -60.59M
max$ 60.64M
average$ 107.22K
median$ 0
std$ 17.65M